Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SURMODICS INC | SVP, Vascular Interventions | Common Stock | 34.7K | $1.38M | $39.91 | Dec 4, 2024 | Direct |
SURMODICS INC | SVP, Vascular Interventions | Employee Stock Option (right to buy) | 29.6K | Dec 4, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SRDX | SURMODICS INC | Dec 4, 2024 | 1 | -$37.8K | 4 | Dec 6, 2024 | SVP, Vascular Interventions |
SRDX | SURMODICS INC | Nov 30, 2024 | 1 | -$51.8K | 4 | Dec 3, 2024 | SVP, Vascular Interventions |
SRDX | SURMODICS INC | Dec 4, 2023 | 2 | $0 | 4 | Dec 6, 2023 | SVP, Vascular Interventions |
SRDX | SURMODICS INC | Nov 30, 2023 | 3 | -$57.4K | 4 | Dec 4, 2023 | SVP, Vascular Interventions |
SRDX | SURMODICS INC | Nov 30, 2022 | 4 | -$32.6K | 4 | Dec 2, 2022 | SVP, Vascular Interventions |
SRDX | SURMODICS INC | Nov 25, 2022 | 1 | -$13.1K | 4 | Nov 29, 2022 | SVP, Vascular Interventions |
SRDX | SURMODICS INC | Nov 30, 2021 | 3 | -$19.2K | 4 | Dec 2, 2021 | Senior VP and CMO |
SRDX | SURMODICS INC | Nov 25, 2021 | 2 | -$57.8K | 4 | Nov 29, 2021 | Senior VP and CMO |